Patrick Auberger
Impact in
- Cancer Research top 0.5%
- NF-κB Signaling Pathways
- Cancer, Hypoxia, and Metabolism
- Hematology top 0.5%
Papers in
-
- Cell death mechanisms and regulation 31
- Metabolism, Diabetes, and Cancer 12
- Immunology 42
- Co-authors
- Alexandre Puissant (29 shared papers)Frédéric Luciano (38 shared papers)Guillaume Robert (47 shared papers)Arnaud Jacquel (46 shared papers)Pascal Colosetti (22 shared papers)Gilles Pagès (12 shared papers)Frédéric Bost (6 shared papers)Bernard Rossi (25 shared papers)
- Journals
- Oncogene (15 papers)Journal of Biological Chemistry (12 papers)The FASEB Journal (11 papers)Oncotarget (8 papers)Blood (7 papers)
- Partner nations
- FranceUnited StatesMorocco
In The Last Decade
Patrick Auberger
190 papers receiving 10.4k citations
Patrick Auberger's Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 1.9k
- Hematology 1.0k
- Molecular Biology 6.1k
- Immunology 1.8k
- Geriatrics and Gerontology 227
Countries citing papers authored by Patrick Auberger
This map shows the geographic impact of Patrick Auberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Auberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Auberger more than expected).
Fields of papers citing papers by Patrick Auberger
This network shows the impact of papers produced by Patrick Auberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Auberger. The network helps show where Patrick Auberger may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Auberger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 192 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level Hit paper breakdown → | 2008 | 732 |
| 2 | Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α Hit paper breakdown → | 1996 | 597 |
| 3 | Defective Thymocyte Maturation in p44 MAP Kinase (Erk 1) Knockout Mice Hit paper breakdown → | 1999 | 544 |
| 4 | Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1 Hit paper breakdown → | 2011 | 529 |
| 5 | 2010 | 436 | |
| 6 | 2003 | 396 | |
| 7 | 2010 | 324 | |
| 8 | 1989 | 282 | |
| 9 | 2011 | 251 | |
| 10 | When autophagy meets cancer through p62/SQSTM1. | 2012 | 220 |
| 11 | 1999 | 196 | |
| 12 | 2004 | 149 | |
| 13 | 2018 | 148 | |
| 14 | 2012 | 134 | |
| 15 | 2000 | 125 | |
| 16 | 2016 | 121 | |
| 17 | 1994 | 120 | |
| 18 | 2012 | 116 | |
| 19 | 2009 | 112 | |
| 20 | 2003 | 106 |
About Patrick Auberger
Patrick Auberger is a scholar working on Molecular Biology, Immunology, Hematology, Oncology and Epidemiology, having authored 192 papers that have together received 10.5k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (31 papers), Autophagy in Disease and Therapy (22 papers), Chronic Myeloid Leukemia Treatments (22 papers), Acute Myeloid Leukemia Research (18 papers), Chronic Lymphocytic Leukemia Research (17 papers), Metabolism, Diabetes, and Cancer (12 papers), NF-κB Signaling Pathways (12 papers) and Peptidase Inhibition and Analysis (10 papers). The work is most often cited by research in Cancer Research (1.9k citations), Hematology (1.0k citations), Molecular Biology (6.1k citations), Immunology (1.8k citations) and Geriatrics and Gerontology (227 citations). Patrick Auberger has collaborated with scholars based in France, United States and Morocco. Frequent co-authors include Alexandre Puissant, Frédéric Luciano, Guillaume Robert, Arnaud Jacquel, Pascal Colosetti, Gilles Pagès, Frédéric Bost, Bernard Rossi, Kathiane Laurent and Jean‐François Tanti. Their work appears in journals such as Oncogene, Journal of Biological Chemistry, The FASEB Journal, Oncotarget and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.